Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study

Adrie Bekker, Helena Rabie, Nicolas Salvadori, Samantha du Toit, Kanchana Than-in-at, Marisa Groenewald, Isabelle Andrieux-Meyer, Mukesh Kumar, Ratchada Cressey, James Nielsen, Edmund Capparelli, Marc Lallemant, Mark F. Cotton, Tim R. Cressey, Unknown

Open source

DOI: 10.1097/qai.0000000000002871
Published: 2021-12-03
Container: JAIDS Journal of Acquired Immune Deficiency Syndromes
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qai.0000000000002871,
  title = {Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study},
  author = {Adrie Bekker and Helena Rabie and Nicolas Salvadori and Samantha du Toit and Kanchana Than-in-at and Marisa Groenewald and Isabelle Andrieux-Meyer and Mukesh Kumar and Ratchada Cressey and James Nielsen and Edmund Capparelli and Marc Lallemant and Mark F. Cotton and Tim R. Cressey and Unknown},
  year = {2021},
  journal = {JAIDS Journal of Acquired Immune Deficiency Syndromes},
  doi = {10.1097/qai.0000000000002871},
  url = {https://doi.org/10.1097/qai.0000000000002871}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study
AU  - Adrie Bekker
AU  - Helena Rabie
AU  - Nicolas Salvadori
AU  - Samantha du Toit
AU  - Kanchana Than-in-at
AU  - Marisa Groenewald
AU  - Isabelle Andrieux-Meyer
AU  - Mukesh Kumar
AU  - Ratchada Cressey
AU  - James Nielsen
AU  - Edmund Capparelli
AU  - Marc Lallemant
AU  - Mark F. Cotton
AU  - Tim R. Cressey
AU  - Unknown
PY  - 2021
JO  - JAIDS Journal of Acquired Immune Deficiency Syndromes
DO  - 10.1097/qai.0000000000002871
UR  - https://doi.org/10.1097/qai.0000000000002871
ER  -

APA

Bekker, A., Rabie, H., Salvadori, N., Toit, S. D., Than-in-at, K., Groenewald, M., Andrieux-Meyer, I., Kumar, M., Cressey, R., Nielsen, J., Capparelli, E., Lallemant, M., Cotton, M. F., Cressey, T. R., & Unknown (2021). Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000002871

Source records

crossref · retrieved 2026-09-26T13:21:33.398Z